PDE inhibitors (Vivus)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NamePDE inhibitors (Vivus)
Drug Alias NamePDE 3 inhibitors (Vivus)PDE5 inhibitors (Vivus)erectile dysfunction therapy (Vivus)PDE 4 inhibitors (Vivus)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 3 inhibitorsPhosphodieterase 4 inhibitorsPhosphodiesterase 5A inhibitors
TargetsPhosphodieterase 4Phosphodiesterase 5APhosphodiesterase 3
Therapy Area/IndicationsErectile Dysfunction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVivus Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVivus Inc
Active IndicationsN/A
Inactive IndicationsErectile Dysfunction

Other Information

ATC CodeN/A
Related LinksN/A